SET Protein Breakthrough in Glioblastoma | Science News

Scientists at Ohio State University have uncovered a protein called SET that acts as a shield for glioblastoma, the deadliest brain cancer, helping tumors resist radiation and chemo. Blocking SET in lab and animal studies halted tumor growth and made cancer cells vulnerable again—without replacing current treatments, but making them work harder. The breakthrough hinges on how glioblastoma disables PP2A, a critical enzyme for cell control; SET helps turn off PP2A, so restoring it could be key. Early tests even suggest an existing antipsychotic might help—though still experimental. This is a major leap toward smarter, more effective therapies for patients with this devastating disease. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/ddb3de6f1a42bf57